Blood Cancer Talks

Episode 56. Management of Newly Diagnosed CML with Dr. Hagop Kantarjian

Feb 12, 2025

01:02:55

In this episode, we discuss the management of CML with Dr. Hagop Kantarjian from MD Anderson Cancer Center. Here are the key articles we discussed:

1. ASC4FIRST RCT: Asciminib in newly diagnosed CML.

https://pubmed.ncbi.nlm.nih.gov/38820078/

2. 5-year follow-up of ENESTnd RCT (nilotinib):

https://pubmed.ncbi.nlm.nih.gov/26837842/

3. 10-year follow-up of ENESTnd RCT (nilotinib):

https://pubmed.ncbi.nlm.nih.gov/33414482/

4. 10-year follow-up of CML-IV RCT (imatinib):

https://pubmed.ncbi.nlm.nih.gov/25676422/

5. MD Anderson data on low-dose dasatinib (50 mg):

https://pubmed.ncbi.nlm.nih.gov/36054032/

https://pubmed.ncbi.nlm.nih.gov/31553487/

6. CML: 2025 update on diagnosis, therapy, and monitoring:

https://pubmed.ncbi.nlm.nih.gov/39093014/

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.

Best podcast app

JD Stuart

App Store

I’ve been using Snipd for about a year and this app has been life changing. I listen to about 17 hours of podcasts a week and I want to take notes on 95% of them. Snipd makes it so easy to do. I can triple click my headphones and record a snip. The app also improves rapidly which is welcomed. It’s an easy subscription for me to pay.

Game Changer

Gpeeps78

App Store

I cannot recommend this app enough. It belongs in my top three AI apps. It’s that good!